Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers.
A series of ruthenium complexes containing bis-benzimidazole derivatives have been synthesized and identified as able to target mitochondria and induce caspase-dependent apoptosis in cancer cells through superoxide overproduction.